BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,737,726 | -6.8% | 280,155 | +18.7% | 0.00% | -25.0% |
| Q2 2023 | $7,227,024 | 0.0% | 236,023 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,227,024 | -25.6% | 236,023 | -5.0% | 0.00% | -20.0% |
| Q4 2022 | $9,718,952 | -99.7% | 248,503 | +322.7% | 0.01% | +150.0% |
| Q3 2022 | $2,800,756,000 | +10.7% | 58,790 | -10.1% | 0.00% | +100.0% |
| Q2 2022 | $2,530,395,000 | -1.4% | 65,368 | +46.0% | 0.00% | 0.0% |
| Q1 2022 | $2,565,722,000 | -20.4% | 44,777 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $3,224,257,000 | -6.5% | 40,460 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $3,449,076,000 | -29.0% | 39,640 | +5.0% | 0.00% | -50.0% |
| Q2 2021 | $4,858,030,000 | +234.4% | 37,744 | +107.9% | 0.00% | +100.0% |
| Q1 2021 | $1,452,807,000 | +36.5% | 18,151 | +39.2% | 0.00% | – |
| Q4 2020 | $1,064,422,000 | – | 13,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |